Open Call in Innovative Medicines Initiative (IMI 2) - Deadline 24 March 2015 (Stage 1)

The Joint Undertaking "Innovative Medicines Initiative (IMI 2)" has published its 3rd Call for proposals.

Deadline:  24 March 2015 – 17:00:00 Brussels time (Stage 1)

Publication Date: 17 December 2014

Weblink (URL): http://www.imi.europa.eu/content/stage-1-14

Short Call Abstract: 

Topics in the IMI 2 3rd Call for proposals are:

  • Topic 1: Remote assessment of disease and relapse - CNS
  • Topic 2: Towards a quantitative biological approach for neuropsychiatry
  • Topic 3: Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
  • Topic 4: The consistency approach to quality control in vaccine manufacture
  • Topic 5: Pertussis vaccination research
  • Topic 6: Knowledge repository to enable patient focused medicine development

SSH aspects: 

SSH aspects can be identified in Topic 2: “Towards a quantitative biological approach for neuropsychiatry“:
Economists should be involved to evaluate the economic impact and value of preventing the onset or delaying the progression of type 2 diabetes. They should model short- and long-term economic and public health morbidity and mortality benefit/risk assessments of a) therapeutic intervention in prediabetes to prevent or delay onset of type 2 diabetes and b) therapeutic interventions in type 2 diabetes for disease modification to reduce the rate of disease progression.

Specific participation requirements: 

PLEASE REFER TO THE CALL TEXT FOR SPECIFIC PARTICIPATION REQUIREMENTS!

 

Social Network Login